Intracanalicular Dexamethasone Insert for the Treatment of Inflammation and Discomfort in Dry Eye Disease (DEcIDED)
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This prospective, single-center, randomized, double-masked, parallel comparison, sponsored
study seeks to investigate the efficacy of Intracanalicular dexamethasone Insert (IDI) on
ameliorating the signs and symptoms of dry eye disease.